• 1. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 2. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 3. An integrated system for field analysis of Cd(ii) and Pb(ii) via preconcentration using nano-TiO2/cellulose paper composite and subsequent detection with a portable X-ray fluorescence spectrometer?
  Xiaofeng Lin RSC Adv., 2016,6, 9002-9006
• 4. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
• 5. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

Professional Introduction to 5-(4-Hydroxyphenyl)-3-trifluoromethoxyphenol (CAS No. 1261900-60-0)

5-(4-Hydroxyphenyl)-3-trifluoromethoxyphenol is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound, identified by its unique Chemical Abstracts Service (CAS) number 1261900-60-0, possesses a molecular structure that combines hydroxyl and trifluoromethoxy functional groups, making it a promising candidate for various biochemical applications. The presence of these functional groups not only enhances its reactivity but also opens up numerous possibilities for its use in drug development and therapeutic interventions.

The compound's structure, featuring a phenolic ring substituted with both a hydroxyl group at the 4-position and a trifluoromethoxy group at the 3-position, contributes to its distinctive chemical properties. These features make it an intriguing subject for researchers exploring novel synthetic pathways and pharmacological targets. The trifluoromethoxy group, in particular, is known for its ability to modulate the electronic properties of the molecule, which can be leveraged to enhance binding affinity and metabolic stability in drug candidates.

In recent years, there has been growing interest in the development of small molecules that can interact with biological targets in novel ways. 5-(4-Hydroxyphenyl)-3-trifluoromethoxyphenol has been studied for its potential as an intermediate in the synthesis of more complex pharmaceutical agents. Its role in the development of bioactive molecules is underscored by its ability to serve as a precursor for compounds that exhibit anti-inflammatory, antioxidant, and even anticancer properties. These potential applications are particularly exciting given the increasing demand for targeted therapies that can address specific pathological conditions.

One of the most compelling aspects of this compound is its versatility in chemical modifications. The hydroxyl and trifluoromethoxy groups provide multiple sites for further functionalization, allowing chemists to tailor the molecule's properties to meet specific therapeutic needs. This flexibility has led to several innovative synthetic strategies being explored, including cross-coupling reactions, nucleophilic substitutions, and palladium-catalyzed transformations. These methods have enabled researchers to create derivatives of 5-(4-Hydroxyphenyl)-3-trifluoromethoxyphenol that exhibit enhanced efficacy and reduced toxicity compared to their parent compound.

The pharmacological profile of 5-(4-Hydroxyphenyl)-3-trifluoromethoxyphenol has been investigated through both in vitro and in vivo studies. Initial findings suggest that this compound interacts with several key biological pathways, making it a potential candidate for treating a range of diseases. For instance, its ability to inhibit certain enzymes involved in inflammation has been observed in cell culture models, indicating its potential as an anti-inflammatory agent. Additionally, preliminary animal studies have shown promising results in reducing oxidative stress and protecting against neurodegenerative damage.

The synthesis of 5-(4-Hydroxyphenyl)-3-trifluoromethoxyphenol involves a series of well-defined chemical steps that highlight the ingenuity of modern synthetic organic chemistry. The process typically begins with the preparation of key intermediates such as 4-hydroxybenzaldehyde and 3-trifluoromethoxybenzoyl chloride. These intermediates are then coupled using palladium-catalyzed cross-coupling reactions to form the desired product. The use of transition metal catalysts not only facilitates these reactions but also allows for high yields and selectivity, which are crucial for large-scale production.

The role of computational chemistry in optimizing the synthesis of 5-(4-Hydroxyphenyl)-3-trifluoromethoxyphenol cannot be overstated. Advanced computational methods have enabled researchers to predict reaction outcomes with remarkable accuracy, thereby reducing the need for trial-and-error experimentation. This approach has led to more efficient synthetic routes and has helped identify new methodologies for constructing complex molecules. By integrating experimental data with computational modeling, scientists have been able to refine their understanding of how different functional groups influence the reactivity and stability of organic compounds.

As research into 5-(4-Hydroxyphenyl)-3-trifluoromethoxyphenol continues to evolve, new applications are likely to emerge. The compound's unique structural features make it a valuable tool for developing innovative therapeutic strategies across multiple disciplines. Whether used as a standalone agent or as part of a larger drug cocktail, this molecule holds significant promise for improving patient outcomes in various medical conditions. The ongoing exploration of its pharmacological properties ensures that it will remain at the forefront of pharmaceutical research for years to come.

The impact of 5-(4-Hydroxyphenyl)-3-trifluoromethoxyphenol extends beyond academic research; it also has implications for industrial applications. Companies specializing in fine chemicals and pharmaceutical intermediates are increasingly interested in this compound due to its potential commercial value. By leveraging cutting-edge synthetic techniques and process optimization strategies, manufacturers can produce high-purity batches of this compound that meet the stringent requirements of modern drug development pipelines.

In conclusion, 5-(4-Hydroxyphenyl)-3-trifluoromethoxyphenol (CAS No. 1261900-60-0) is a multifaceted compound with a wide range of potential applications in pharmaceutical chemistry and medicinal research. Its unique molecular structure, combined with its reactivity and pharmacological profile, makes it an attractive candidate for further exploration. As research continues to uncover new ways to utilize this compound, it is likely to play an increasingly important role in the development of next-generation therapeutics.

• 1261919-56-5(5-(4-Methylphenyl)-3-trifluoromethoxyphenol)
• 1261926-25-3(5-Phenyl-3-trifluoromethoxyphenol)
• 1261934-51-3(5-(4-Trifluoromethoxyphenyl)-3-trifluoromethoxyphenol)
• 1261889-01-3(5-(3-Methylphenyl)-3-trifluoromethoxyphenol)
• 1261903-44-9(3-(Naphthalen-2-yl)-5-(trifluoromethoxy)phenol)
• 1237747-77-1(3-(4-Trifluoromethoxyphenyl)phenol)
• 1261897-09-9(3-Methyl-5-(4-trifluoromethoxyphenyl)phenol)
• 1261919-88-3(5-(3,5-Dimethylphenyl)-3-trifluoromethoxyphenol)
• 71274-84-5(1,1'-Biphenyl,4-(trifluoromethoxy)-)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)